InsidersTradesSigma
Follow the 我武生物 stock price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 我武生物 has logged 2 reports. Market capitalisation: €12.4bn. The latest transaction was disclosed on 27 June 2022 (Sale). Among the most active insiders: 胡赓熙. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
我武生物 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of biological products.